Ingmar Gorman, Ph.D.

Ingmar Gorman, Ph.D. is a clinical psychologist with extensive experience in psychedelic research and therapy. He co-founded and serves as CEO of Fluence, a company focused on psychedelic education. Gorman has worked on several clinical trials, including MAPS' Phase II and III trials for MDMA-assisted psychotherapy for PTSD. He is a respected expert in his field and has published numerous papers on psychedelic research. Gorman is based in the United States.